Post-Marketing Surveillance (Use-results Surveillance) With Esperoct®
NCT04334057
·
clinicaltrials.gov ↗
COMPLETED
Status
23
Enrollment
INDUSTRY
Sponsor class
Conditions
Haemophilia A
Interventions
DRUG:
Turoctocog alfa pegol
Sponsor
Novo Nordisk A/S